Cranberry Supplementation, Viral Defense, Antibody Response to the Flu Shot
NCT04597554 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84
Last updated 2022-02-21
Summary
This study will investigate the effect of 8-weeks cranberry supplementation on the antibody response to influenza vaccination and ex-vivo anti-viral activity. The hypothesis is that 8-weeks ingestion of cranberry supplement relative to placebo will improve the antibody response to influenza vaccination and ex-vivo anti-viral defense.
Conditions
- Nutrition Immunology
Interventions
- DIETARY_SUPPLEMENT
-
Cranberry
Cranberry beverage and gummies supplement
- DIETARY_SUPPLEMENT
-
Placebo
Placebo beverages and gummies supplement
Sponsors & Collaborators
-
Ocean Spray, Inc.
collaborator INDUSTRY -
Appalachian State University
lead OTHER
Principal Investigators
-
David C Nieman · Appalachian State Univ
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-21
- Primary Completion
- 2020-11-30
- Completion
- 2021-12-31
Countries
- United States
Study Locations
More Related Trials
-
Immune Response Study of Influenza Vaccine
NCT01310374 ·Status: COMPLETED
-
Effect of Blueberries on Immunity
NCT05534893 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine
NCT03300050 ·Status: COMPLETED ·Phase: PHASE1
-
Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain
NCT05572450 ·Status: COMPLETED ·Phase: NA
-
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
NCT04579588 ·Status: RECRUITING
-
A Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine
NCT03718468 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Response to Influenza Vaccination
NCT00551837 ·Status: COMPLETED
-
Cholecalciferol and Flu Vaccine in Treating Healthy Participants
NCT01561989 ·Status: TERMINATED ·Phase: NA
-
Safety Study of an Oral Vaccine to Prevent Seasonal Influenza
NCT01688297 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza
NCT03903718 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults
NCT01059617 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of FLU Vaccination on Nasal Resident Memory Immune Responses and Peripheral Respiratory-tropic Memory Immune Responses
NCT06824779 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines
NCT01191853 ·Status: COMPLETED
-
Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus
NCT01023711 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects
NCT00845429 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines
NCT00644059 ·Status: COMPLETED ·Phase: PHASE3
-
Development of Childhood Anti-Influenza Immunity
NCT03673345 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of BCG on Influenza Induced Immune Response
NCT02114255 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults
NCT01730144 ·Status: COMPLETED
-
Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity
NCT01896154 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Multicenter, Double-blind, Parallel Phase III Study
NCT02352584 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects
NCT03657719 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Immune Responses to Influenza Vaccination
NCT03346772 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults
NCT01776541 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 Vaccine
NCT00995527 ·Status: COMPLETED